RxDoctor Payments DataLook up a doctor →

Daniel Wynn, MD

Neurology · Northbrook, ILNPI 1710971700

Payments from drug & device makers

$13,932,455in general payments, 2019–2025

Across 3,726 payments — averaging $3739.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$7.7M
  • Sanofi$2.9M
  • F. Hoffmann-la Roche AG$498K
  • Adamas Pharmaceuticals, Inc.$494K
  • TG Therapeutics, Inc.$478K
  • Eli Lilly$412K
  • plus $1.4M from 54 others
$36,153in research payments, 2019–2025

Across 58 payments — averaging $623.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • TG Therapeutics, Inc.$20K
  • Sanofi US Services Inc.$9K
  • Eli Lilly$4K
  • Sanofi$2K
  • EMD Serono, Inc.$1K
  • Merck Healthcare Kgaa$39

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis92$7,746,379
Sanofi558$2,899,036
F. Hoffmann-la Roche AG98$498,317
Adamas Pharmaceuticals, Inc.124$493,724
TG Therapeutics, Inc.157$477,856
Eli Lilly4$412,399
EMD Serono, Inc.407$331,865
Sanofi US Services Inc.4$176,548
Genentech, Inc.17$149,589
Hoffmann-la Roche Limited18$92,663
E.r. Squibb & Sons, L.L.C.70$92,330
Mallinckrodt Hospital Products Inc.63$85,116
Roche Products Limited22$62,340
Jazz Pharmaceuticals Inc.26$48,497
Chugai Pharmaceutical Co., Ltd.26$41,636
Sunovion Pharmaceuticals Inc.27$39,963
Mallinckrodt Enterprises LLC10$37,506
Bristol Myers Squibb132$30,684
AbbVie(2 entities)292$30,625
Amgen(2 entities)86$28,156
Mylan Specialty L.p.14$23,732
Avanir Pharmaceuticals, Inc.93$22,491
Teva Pharmaceuticals USA, Inc.159$16,522
Genentech USA, Inc.29$13,501
Johnson & Johnson40$12,038
Vanda Pharmaceuticals Inc.40$9,819
Banner Life Sciences, LLC5$9,042
Eisai Inc.22$8,463
Greenwich Biosciences, Inc.6$6,411
ANI Pharmaceuticals, Inc.34$6,352
Mylan Pharmaceuticals Inc.6$4,358
Mylan Institutional Inc.6$2,231
UCB, Inc.87$2,069
Viatris Specialty LLC1$1,466
Pfizer85$1,188
Lundbeck LLC73$1,167
Lilly USA, LLC53$1,055
Neurocrine Biosciences, Inc.53$1,034
Currax Pharmaceuticals LLC86$966
AstraZeneca(2 entities)43$954
Ares Trading SA11$935
Beigene, Ltd.1$888
Supernus Pharmaceuticals, Inc.94$776
Biogen32$749
MDD US Operations, LLC16$712
Axsome Therapeutics, Inc.33$700
Avadel CNS Pharmaceuticals, LLC17$564
Argenx US, Inc.10$502
Harmony Biosciences LLC18$416
Takeda Pharmaceuticals U.S.A., Inc.21$404
Hospira, Inc.15$380
CSL Behring7$337
Catalyst Pharmaceuticals, Inc.13$327
Upsher-smith Laboratories LLC17$302
SK Life Science, Inc.17$299
Otsuka America Pharmaceutical, Inc.14$289
Arbor Pharmaceuticals, Inc.23$282
Acorda Therapeutics, Inc12$237
Sanofi-aventis U.S. LLC7$212
Abbott9$207

How this compares

$13,932,455 in reported general payments places this provider in the 95th percentile of 790 neurology providers in Illinois.

See all neurology providers in Illinois

Medicare billing

Part B allowed, 2024
$74,242
Medicare patients
253
Services billed
460

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Northbrook

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →